Juan Manuel Irache Garreta-rekin lankidetzan egindako argitalpenak (22)

2020

  1. In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer

    Drug Delivery and Translational Research, Vol. 10, Núm. 3, pp. 635-645

2019

  1. In vitro characterization of new stabilizing albumin nanoparticles as a potential topical drug delivery system in the treatment of corneal neovascularization (CNV)

    Journal of Drug Delivery Science and Technology, Vol. 52, pp. 379-385

  2. In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization

    Experimental Eye Research, Vol. 185

2018

  1. Human serum albumin nanoparticles for ocular delivery of bevacizumab

    International Journal of Pharmaceutics, Vol. 541, Núm. 1-2, pp. 214-223

2015

  1. Casein nanoparticles as carriers for the oral delivery of folic acid

    Food Hydrocolloids, Vol. 44, pp. 399-406

2014

  1. Superparamagnetic maghemite loaded poly (ε-caprolactone) nanocapsules: Characterization and synthesis optimization

    Revista Materia

  2. Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) - Pluronic® F127 copolymers for controlled protein release

    International Journal of Pharmaceutics, Vol. 459, Núm. 1-2, pp. 1-9

2013

  1. Nanoparticules mucopénétrantes : Véhicules pour l'administration orale du paclitaxel

    Annales Pharmaceutiques Francaises, Vol. 71, Núm. 2, pp. 109-118

  2. Optimization of maghemite-loaded PLGA nanospheres for biomedical applications

    European Journal of Pharmaceutical Sciences, Vol. 49, Núm. 3, pp. 343-351

  3. Resveratrol/Maghemite loaded superparamagnetic PCL nanocapsules: new approach for cancer therapy

    PAKISTAN JOURNAL OF MEDICAL SCIENCES, Vol. 1, Núm. 2, pp. 30-31

2012

  1. Molecular buckets: Cyclodextrins for oral cancer therapy

    Therapeutic Delivery, Vol. 3, Núm. 1, pp. 43-57

  2. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 81, Núm. 3, pp. 514-523

  3. Stabilized micelles as delivery vehicles for paclitaxel

    International Journal of Pharmaceutics, Vol. 436, Núm. 1-2, pp. 258-264

2011

  1. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery

    Expert Opinion on Drug Delivery, Vol. 8, Núm. 6, pp. 721-734

  2. Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone

    Biomedical Microdevices, Vol. 13, Núm. 6, pp. 1015-1025

  3. Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles

    Molecular Imaging and Biology, Vol. 13, Núm. 6, pp. 1215-1223

  4. Nanomedicine: Novel approaches in human and veterinary therapeutics

    Veterinary Parasitology, Vol. 180, Núm. 1-2, pp. 47-71

2010

  1. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles

    Journal of Controlled Release, Vol. 145, Núm. 1, pp. 2-8

2009

  1. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles

    European Journal of Pharmaceutical Sciences, Vol. 37, Núm. 3-4, pp. 231-240

  2. Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel

    European Journal of Pharmaceutical Sciences, Vol. 38, Núm. 4, pp. 405-413